Lakefront Biotherapeutics (LKFT) Net Cash Flow Growth (1y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) Net Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | -182.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.52% |
| Dec 31, 2025 | 86.86% |
| Sep 30, 2025 | -15.53% |
| Jun 30, 2025 | 43.61% |
| Mar 31, 2025 | 138.36% |
| Dec 31, 2024 | -19.18% |
| Mar 31, 2024 | 72.48% |
| Dec 31, 2023 | 84.36% |
| Mar 31, 2023 | 61.23% |
| Mar 31, 2022 | -208,352.51% |
| Jun 30, 2021 | 99.43% |
| Mar 31, 2021 | -99.94% |
| Jun 30, 2020 | -364.29% |
| Mar 31, 2020 | 1,265.29% |
| Dec 31, 2019 | -5,960.55% |
| Sep 30, 2019 | 1,165.92% |
| Jun 30, 2019 | -9.11% |
| Mar 31, 2019 | -52.30% |
| Dec 31, 2018 | -156.55% |
| Sep 30, 2018 | 100.09% |